06185.HK
CanSino Biologics, Inc.
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 25.78
−0.46%Next report
Analyst consensus
- Next report date
- Mar 30, 2027
- EPS estimate
- HKD 0.38
- Revenue estimate
- HKD 662.3M
Latest reported
- Last report date
- Oct 27, 2026
- EPS actual
- HKD 0.08
- EPS estimate
- HKD 0.29
- Revenue actual
- HKD 388.6M
- Revenue estimate
- HKD 466.7M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -47.0%
- Revenue beats (12Q)
- 1
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Oct 27, 2026 | HKD 0.29 | HKD 0.08 | Miss -72.20% | HKD 388.6M |
| Aug 27, 2026 | HKD 0.24 | HKD 0.19 | Miss -21.75% | HKD 411.5M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 30, 2027